DIMENSIONAL FUND ADVISORS LP - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 156 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 4.14 and the average weighting 0.2%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$174,000
+14.5%
23,5700.0%0.00%
Q4 2021$152,000
+10.9%
23,5700.0%0.00%
Q3 2021$137,000
-45.0%
23,570
-2.1%
0.00%
Q2 2021$249,000
-83.9%
24,084
-83.6%
0.00%
-100.0%
Q1 2021$1,542,000
-32.0%
146,6030.0%0.00%0.0%
Q4 2020$2,269,000
-77.7%
146,603
-79.0%
0.00%
-75.0%
Q3 2020$10,185,000
-31.1%
697,608
-10.7%
0.00%
-33.3%
Q2 2020$14,787,000
-29.3%
780,850
-28.3%
0.01%
-45.5%
Q1 2020$20,923,000
-7.4%
1,089,102
-7.6%
0.01%
+37.5%
Q4 2019$22,606,000
+94.2%
1,179,239
-2.6%
0.01%
+60.0%
Q3 2019$11,643,000
+75.9%
1,210,267
+9.5%
0.01%
+66.7%
Q2 2019$6,618,000
+0.3%
1,104,850
-2.2%
0.00%0.0%
Q1 2019$6,599,000
+4.5%
1,129,958
+67.7%
0.00%0.0%
Q4 2018$6,313,000
+42.4%
673,774
+158.8%
0.00%
+50.0%
Q3 2018$4,434,000
-15.4%
260,365
-15.6%
0.00%0.0%
Q2 2018$5,239,000
+24.6%
308,356
-1.6%
0.00%0.0%
Q1 2018$4,205,000
+38.6%
313,356
-0.8%
0.00%
+100.0%
Q4 2017$3,033,000
-13.4%
315,890
-1.0%
0.00%
-50.0%
Q3 2017$3,503,000
+19.6%
319,042
-1.4%
0.00%
+100.0%
Q2 2017$2,930,000
-17.3%
323,671
+17.3%
0.00%
-50.0%
Q1 2017$3,543,000
+44.4%
275,972
+5.7%
0.00%
+100.0%
Q4 2016$2,454,000
+332.0%
261,055
+347.5%
0.00%
Q3 2016$568,00058,3410.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Consonance Capital Management LP 4,767,078$80,993,0005.22%
Palo Alto Investors LP 4,663,324$79,230,0003.17%
DOHENY ASSET MANAGEMENT /CA 282,945$4,807,0002.61%
Private Capital Advisors, Inc. 416,900$7,083,0002.22%
Sandia Holdings, LLC 119,739$2,034,0000.91%
Virtus ETF Advisers LLC 44,986$764,0000.68%
Birchview Capital, LP 50,000$850,0000.58%
Schonfeld Strategic Advisors LLC 415,600$7,061,0000.38%
EMERALD ADVISERS, LLC 561,317$9,537,0000.36%
Kazazian Asset Management, LLC 20,672$351,0000.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders